Korsana Biosciences Inc. (KRSA)
KRSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$31.66
-6.99% on the day
Market cap
$1.4B
Small cap
Revenue · 2025
$2.1M
+3.7% on 2024
Net income · 2025
-$3.5M
-170.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | KRSA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001755237 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | MA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.1M |
| Net income | -$3.5M |
| Operating income | -$5.0M |
| Net margin | -170.1% |
| Operating margin | -239.8% |
| Revenue growth | +3.7% |
| Cash | $3.2M |
| Total assets | $10.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 695.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-24 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-09-11 |
| Latest proxy | PRE 14A | 2026-10-05 |
Source: SEC EDGAR submissions feed, 386 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.8% |
| 1 month | +3.4% |
| 3 months | +29.5% |
| Year to date | +273.2% |
| 1 year | +106.1% |
| From 52-week high | -25.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $15.06 | -1.63% | $1.4B |
| KLRA | Kailera Therapeutics Inc. | $10.77 | -4.94% | $1.4B |
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| RAPP | Rapport Therapeutics Inc. | $28.99 | -3.85% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier